AU2024204859A1 — Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
Assigned to Cytokinetics Inc · Expires 2024-08-01 · 2y expired
What this patent protects
Provided are compounds of Formula (I): R2 G 1-G 2 R1 A O G3 HN R3 Z-B Formula (I) or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R', R2 , R3 , G 1, G2,and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a…
USPTO Abstract
Provided are compounds of Formula (I): R2 G 1-G 2 R1 A O G3 HN R3 Z-B Formula (I) or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R', R2 , R3 , G 1, G2,and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof. 346
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.